Cargando…
Identification of MTHFD2 as a novel prognosis biomarker in esophageal carcinoma patients based on transcriptomic data and methylation profiling
DNA methylation is an important epigenetic regulatory mechanism in esophageal carcinoma (EC) and is associated with genomic instability and carcinogenesis. In the present study, we aimed to identify tumor biomarkers for predicting prognosis of EC patients. We downloaded mRNA expression profiles and...
Autores principales: | Wang, Jianlin, Luo, Judong, Sun, Zhiqiang, Sun, Fei, Kong, Ze, Yu, Jingping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489726/ https://www.ncbi.nlm.nih.gov/pubmed/32925794 http://dx.doi.org/10.1097/MD.0000000000022194 |
Ejemplares similares
-
Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC)
por: Wang, Jian, et al.
Publicado: (2021) -
KIF26B in the Prognosis and Immune Biomarking of Various Cancers: A Pan-Cancer Study
por: Sun, Fei, et al.
Publicado: (2022) -
A novel prognosis prediction of esophageal cancer based on chromatin regulator-related lncRNA
por: Wang, Yuchen, et al.
Publicado: (2023) -
Clinicopathological analysis of 67 cases of esophageal neuroendocrine carcinoma and the effect of postoperative adjuvant therapy on prognosis
por: Liu, Shenxiang, et al.
Publicado: (2021) -
RAI14 silencing suppresses progression of esophageal cancer via the STAT3 pathway
por: Wang, Jianlin, et al.
Publicado: (2020)